About the Product

Description


Lactitol 66.67% syrup is an osmotic laxative formulation used for managing constipation by increasing water content in the colon and softening stools for easier bowel movements.

It acts by drawing water into the large intestine, promoting peristalsis, and facilitating smoother, more regular defecation without causing harsh irritation.

This syrup is widely recommended in chronic constipation management, postoperative bowel care, and general digestive support, ensuring patient comfort and improved gastrointestinal function.

With consistent therapeutic effectiveness, easy administration, and high acceptance in hospitals and clinics, this syrup enhances a gastroenterology portfolio and supports steady demand in constipation relief therapy.

Common side effects may include mild bloating, abdominal discomfort, flatulence, or mild diarrhea. These effects are generally temporary and resolve with dosage adjustment. Severe gastrointestinal upset is rare.

Lactyle Syrup is indicated for the management of chronic constipation, occasional constipation, and bowel irregularities. It may also be used to improve bowel movement consistency in patients requiring gentle laxative therapy, as advised by a healthcare professional.

Use under medical supervision. Avoid excessive use as it may lead to dehydration or electrolyte imbalance. Not recommended for patients with galactosemia or intestinal obstruction. Ensure adequate hydration during therapy.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Lactitol 66.67% w/v Syrup in the PCD pharma franchise market?

Lactitol Syrup is a laxative used for constipation, hepatic encephalopathy support, and bowel regulation, making it a strong gastroenterology segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this syrup in their product range?

Medical distributors and wholesalers can benefit from consistent demand in gastro clinics, chronic constipation cases, and hospital prescriptions. It is commonly prescribed for long-term bowel regulation and liver-related toxin management support.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Lactitol Syrup with monopoly rights, quality gastro manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this gastro product?

Wholesalers and medical agencies benefit from steady chronic constipation management demand, hospital usage, and long-term gastroenterology prescriptions when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Lactitol Syrup?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this gastro formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.